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ABSTRACT 
Objective:  Epilepsy is one on of the commonest neurological problem seen in neurology and the ultimate aim is 
to manage the fits. Despite giving various medicines, fits are not controlled in some patients. This study has been 
carried out to define various factors which account for poor control of fits in these patients. These include 
incorrect diagnosis of epilepsy, under dosage, improper selection of the drugs, noncompliance of the patient, lack 
of education, etc. If proper emphasis were given to all these factors while treating the patient of epilepsy, fits can 
be effectively controlled in the majority of the patients. 
Material and Methods:  It was a retrospective and prospective study. The duration of study was six months from 
1st January to 31st Dec 2016. The study has been carried in the department of neurology, Gujranwala medical 
college/DHQ teaching hospital Gujranwala. 
Results:  A total number of hundred patients were entered into the study. This was a heterogeneous group 
according to gender and age. There were a total of 62 (62%) males, and 38 (38%) females. Out of total 100 
patients, 86 had idiopathic epilepsy which constitutes 86% of total patients. Four (4%) had fits following 
meningitis. There were no patients with a history of fits following trauma. There were four (4%) patients who had 
a brain tumor. 
Conclusion:  It is concluded from our study that: Idiopathic Epilepsy is the commonest among etiology of fits 
almost (86%). Tonic clonic generalized epilepsy is the commonest type of presentation for Epilepsy (76%). The 
control of seizures can be improved by education/councelling of the patients. 
 
INTRODUCTION 
This study aims to find out different factors that affect 
control of fits in 100 patients. After study it was found 
out that the following factors affect control of fits in 
the patient population.While diagnosing and treating 
epilepsy, one must consider the patient’s age. This is 
important because the etiology of epilepsy is different 
at different age. As, for example, perinatal hypoxia 
and congenital malformation are the most important 
causes of fits in infants (0-2). On the other hand brain 
tumor and CVAs are the commonest causes in older 
adults.Seizures at different ages are because of 
different reasons. As it has already been mentioned 
that the onset of fits at different ages is important for 
diagnosis and treatment point of view.Once the 
etiology of epilepsy is known, one must classify the 
type of epilepsy. That is again important for the 
treatment of fits. For example, in case of partial 
seizures the first line drug is carbamazepine or 
levetiracetam. In contrast, Valproic acid is the first line 
drug for generalized tonic clonic seizures.It has been 
seen that in some cases the fits are not controlled even 
though the patient is given antiepileptic therapy. The 
reason is that underlying illness is not fully known. So 
it is important that underlying illness should also be 
treated in addition to the treatment of fits. In some 
case, however, it may be electrolyte imbalance or 
some other problem.In many cases the fits are not 
controlled because the proper antiepileptic drug is not 
instituted. So selection of proper anti-epileptic therapy 
is extremely important for the control of fits.In some 
cases it has been seen that patients do not take the drug 
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in proper dosage or they don’t take medicines at all at 
times. Underdosage leads to lack of control of fits. 
This should be managed properly. 
 Education is important for the proper treatment 
fits. It has been seen that educated patients take 
medicines regularly and have better control of fits. 
Awareness of the disease is important and educated 
patients obviously have better awareness.The fits are 
difficult to control in mentally retarded patients 
because they do not understand their illness to have 
better control of fits. To have better control of fits they 
should have regular medications and sometimes they 
need multiple drugs at the same to control of fits. 
Intercurrent illness should be treated because these 
cause fits, which are controlled when the patients are 
febrile. 
 
MATERIALS AND METHODS 
We randomly selected 100 patients with age 13 years 
and above and both males and females were selected. 
It was a retrospective and prospective study. The 
duration of study was six months from 1st January to 
31st Dec 2016. The study has been carried in the 
department of neurology, Gujranwala medical college/ 
DHQ teaching hospital Gujranwala. One hundred 
patients were randomly selected who were following 
the neurology OPD for years for the treatment of 
epilepsy. EEG was done in all patients and findings 
were recorded. The CT brain, MRI brain and CSF 
were done where required. Serum levels were not done 
because these are very expensive and most of these are 
not available locally. So we have to rely on the history 
as regard the complaints.  A detailed history was taken 
from all the patients, their relatives and eye witnesses. 
Then thorough general and physical examination was 
done. All the patients had routine laboratory checkup. 
A performa was designed for patients record and 
follow-up. 
 
Selection Criteria 
Patients having confirmed epilepsy with recurrent fits 
as a major complain were selected. And it has already 
been mentioned that all males and females above the 
age of 13 years were selected. 
 
Exclusion Criteria 
1. Patients having major psychiatric symptoms were 
not included in the study. Patients under the age of 
12 were not included in the study as these refer to
pediatric department. 
2. Patient with autoimmune diseases were also 
excluded from the study. 
 
Follow-up Methodology 
At each OPD visit, following initial work-up, and 
interval history was obtained regarding the status of 
the illness. This included a number of fits-type of 
occurrence, schedule of daily activities, inquiry was 
made about school, job, social interaction, recreation, 
behavior of family, treatment issues included, any 
change in dose, dose adjustments, drug withdrawal, 
psychological & social problems, prevention of 
unnecessary dependence, stress on compliance 
(directly to the patient), permission regarding driving, 
swimming, and operating machinery. All these 
informations were recorded in the designed performa. 
 
RESULTS 
A total number of hundred patients were entered into 
the study. 
 
Gender and Age Incidence 
This was a heterogeneous group according to gender 
and age. There were a total of 62 males, which 
comprise 62% of population as opposed to 38 females, 
which constituted 38% of total patients. 
 
Etiological Factors 
Table 1 shows that out of total 100 patients, 86 had 
idiopathic epilepsy which constitutes 86% of total 
patients. 4 percent had fits following meningitis which, 
constitutes the same percentage. There were no 
patients with a history of fits following trauma. There 
were four patients which had a brain tumor. Post 
stroke cases were four that developed fits and same 
percentage was constituted. 
 
Table 1:  Etiology of Fits. 
 
Causes  No. of patients % age 
Idiopathic 86 86 
Post meningitic   4   4 
Post traumatic - - 
Tumor related   4   4 
Post stroke   4   4 
Post-partum   2   2 
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Table 2:  Various Types of Epilepsies. 
 
Type of Seizures No. of Patients 
Generalized  
 Tonic clonic 76 
 Clonic - 
 Tonic   6 
Partial  
 Jacksonian    6 
 Complex partial   6 
 Myoclonic    6 
 
 Only two patients developed fits following 
delivery and again the same percentage was added. 
 
Types of Epilepsy 
Table 2 shows various types of epilepsies which were 
under study. Out of 100 patients, 76 had generalized 
tonic clonic, 6 had tonic and there was no patient with 
clonic fits. As for partial seizures, 6 has Jacksonian fits 
and 6 had complex partial seizures, and 6 patients had 
myoclonic seizures. This was done on the basis of the 
history of the patient and an eye witness account of the 
episode. 
 
Aura Symptoms 
Out of 100 patients, only 36 had some type of warning 
before attack, in rest of the patient there was no aura. 
Distribution of these aura symptoms is given in the 
table 3. 
 
Table 3:  Frequency of Symptoms of Aura. 
 
Symptoms No. of Patients 
Twisting of face or arm 2 
Feeling of numbness of whole body 2 
Headache 4 
Sinking of heart 8 
Epigastric pain Nil 
Dizziness 6 
Unable to speak 4 
Strange feeling 2 
Slurred speech 2 
Palpitation 2 
 
 The study was done in 100 patients. The duration 
varied from as short as one week to as long as twenty 
years. The average age was between 20-25 years. 
 Proper diagnosis Educatory Councelling of the 
patients was done and all cases and we are able to 
control the fits in (90%) cases. 
 
DISCUSSION 
The aim was this study was to find out prevention of 
different factors which affect control of epilepsy in 
patient population presenting to the neurology 
department at Gujranwala medical college/DHQ 
teaching hospital Gujranwala. It was thought that this 
aim could help in better management of fits. It had 
been seen during the study that many patients had poor 
control on fits. In a study of hundred patients, 15 
percent of the patients had poor control of fits. It was 
seen that in some patients that they were not taking 
medicines at all. One reason was that in these patients’ 
disease was not diagnosed properly. For example, in 
two elderly patients who came with a history of fits for 
about two weeks, were taking carbamazepine in 
normal adult doses but fits were not controlled. Brain 
imaging was then advised and it showed SOL which 
was later operated and the patients became symptom 
free. In ten patients the fits were not controlled 
because the patients were not taking medicines 
regularly.
1,2
 The reason was that the patients were not 
aware of the disease. To such patients literature about 
epilepsy was provided so that they could have 
awareness about the disease and can take 
precautionary measures. In six patients who had 
generalized epilepsy, fits were not controlled. They 
were ultimately diagnosed as having myoclonic 
epilepsy.
3,4
 Four of these were females and were 
sisters. They were diagnosed as a case of Lafora body 
disease
5-9
 The diagnosis was made on the basis of 
history. The partial control of fits was achieved 
through sodium valproate and clonazepam.
10-12
 These 
three had been bed bound for a long time. Two sisters 
died of severe chest infection. The youngest sister 
improved to the extent that the frequency of fits has 
comparatively decreased. Unfortunately, she lost 
follow up later on. We have seen during the study, the 
EEG was abnormal in 75% of cases.
13
 We also 
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included those who had fits following stroke. These 
were four such patients who developed fits following 
cerebrovascular accidents. So, this actually constituted 
4% of all patients. This was consistent with Rochester 
study.
14-16
 
 We also have come across two patients who 
developed fits secondary to brain SOL that was 
actually 4% of all patients. Rochester’s study suggests 
the same.
17-20
 We also had four patients who developed 
seizures following meningitis. This constituted four 
percent of all patients under study.
21
 Among 100 
patients, which were under study, 62% were males and 
38% were females. 52 males had good control over fits 
while 10 patients did not respond to the treatment. 
Many of the studies done in the past were consistent 
with these findings. There were cases in the study 
done in the past in which patients developed fits 
following neurofibromatosis, tuberous sclerosis, 
protwine stain, subungual fibroma, and unfortunately 
we did not come across such patients. During the 
study, the aim was to study the prevalence of different 
factors which affect the control of fits. Following this 
study, we tried to correctly diagnose the seizure type 
and to select proper antiepileptic drugs. The patients 
were also educated with hand literature to cope with 
the disease. The outcome was encouraging. The 
seizures were then under control in the majority of the 
patients and in the rest at least the frequency of fits 
was decreased. 
 
CONCLUSION 
It is concluded from our study that: Idiopathic 
Epilepsy is the commonest among etiology of fits 
almost (86%). Tonic clonic generalized epilepsy is the 
commonest type of presentation for Epilepsy (76%). 
The control of seizures can be improved by 
education/councelling of the patients. 
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